Navigation Links
Heart has enough oxygen to survive hypothermia, CPR crucial

Researchers from Norway may have ruled out insufficient oxygen supply to the heart as the critical variable in whether a mammal's heart survives while in a hypothermic state.

Writing in the July issue of the American Journal of Physiology-Heart and Circulatory Physiology, researchers found no significant difference in the amount of oxygen available to the heart between rats exposed to one hour of severe hypothermia and rats exposed to five hours. However, the rats in the five-hour group were more likely to experience fatal heart failure during rewarming.

The issue is important because the rewarming of victims of severe hypothermia almost always causes heart failure of varying severity, but little is known about why that happens, said Torkjel Tveita, the study's senior researcher. Tveita is an anesthesiologist who treats victims of hypothermia, including fishermen who have fallen into the frigid Norwegian waters, and cross-country skiers marooned in bad weather.

"We still do not know the pathophysiological mechanism of hypothermia, which is necessary to developing the best way to rewarm hypothermia victims," Tveita explained. This study -- which examined the effect hypothermia had on the heart, not on other vital organs such as the brain -- is a step in that direction.

Timofei V. Kondratiev, Kristina Flemming, Eivind S.P. Myhre, Mikhail A. Sovershaev and Tveita did the study "Is oxygen supply a limiting factor for survival during rewarming from profound hypothermia?" The study is published by The American Physiological Society. The researchers are from the University of Tromsø (Norway) and University Hospital of North Norway.

"Due to the limited amount of oxygen the body needs when hypothermic, I want to stress the importance of starting and continuing cardiopulmonary resuscitation (CPR) efforts with all victims of hypothermia," Tveita said. Doctors typically cease CPR efforts in a normothermic patient after 30 minutes. Bu
'"/>

Source:American Physiological Society


Page: 1 2 3 4

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. Implanted Devices Detect High-Risk Heart Failure Patients
3. Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments
4. Special Imaging Study Shows Failing Hearts Are Energy Starved
5. Stem Cell Research Shows Potential for Replacing Tissue Damaged in Heart Attacks
6. Heart repair gets new muscle
7. Male Combat Veterans Rank High In Heart Disease Risk
8. Newly Discovered Role for Heart Response Enzyme May Yield Better Heart Failure Therapy
9. Researchers Find Drug May Give Some Cardiac Protection 24 Hours After Heart Attack
10. Heart-healthy compound in chocolate identified
11. Heart smart: new drug improves blood flow
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Heart has enough oxygen survive hypothermia CPR crucial

(Date:12/17/2014)... Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major ... demand for medical sensors in biomedical applications. Chemical ... quick and correct diagnosis during surgical procedures. The ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... domain . . . With the ... National Laboratory,s Center for Nanophase Materials Sciences, scientists ... open new pathways for nanoscale electronics. The study, ... ) and led by Ramamoorthy Ramesh of Lawrence ...
... avoid creating greenhouse gases, it makes more sense using ... reserves than to plow it up for corn to ... "Converting set-asides to corn-ethanol production is an inefficient ... be encouraged until ethanol-production technologies improve," the study,s authors ...
... ongoing mission to train and educate scientists on the ... Craig Venter Institute,s (JCVI) Eukaryotic Genome Annotation and Analysis ... train 40 United States Agriculture Department (USDA) scientists at ... will focus on the use of JCVI,s eukaryotic annotation ...
Cached Biology News:Story tips from the Departments of Energy's Oak Ridge National Lab -- March 2009 2Story tips from the Departments of Energy's Oak Ridge National Lab -- March 2009 3Study critiques corn-for-ethanol's carbon footprint 2Study critiques corn-for-ethanol's carbon footprint 3JCVI program trains USDA scientists on eukaryotic genome analysis 2
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... , Dec. 22, 2014   ... a developer of pathogen-specific therapies for serious ... protecting the microbiome, today announced positive topline ... 1a clinical trial of SYN-004, the Company,s ... of Clostridium difficile (C. difficile) ...
(Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
(Date:12/22/2014)... , Dec. 22, 2014  ( www.competitivehealth.com ) ... an online medical bill review and advocacy service, has ... the FREE WellCard Savings discount health services marketplace. ... that was more than they expected to pay. As ... health care costs, WellCard Savings is pleased to offer ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
... for In-Vitro / In-Vivo ... Correlation Modeling in Drug Development, MOUNTAIN VIEW, ... a leading provider of software, strategic,consulting, and regulatory services ... MS, Director of,Training and Pre-Sales, will speak to members ...
... Insmed Inc. (Nasdaq:,INSM), a developer of follow-on ... request a hearing before The NASDAQ Listing,Qualifications Panel ... delist the Company,s common stock from The NASDAQ ... The NASDAQ Stock Market ("NASDAQ") on,June 17, 2008 ...
... 2008 / b3c newswire /  - Rentschler ... biopharmazeutischer Arzneimittel gibt die Inbetriebnahme einer 2.500 ... nun über neun unabhängige GMP-Produktionslinien mit Arbeitsvolumen ... für die Herstellung von klinischen Prüfmustern und ...
Cached Biology Technology:Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference 2Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference 3Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination 2Rentschler Biotechnologie erweitert Kapazitten fr Produktion in Sugetierzellen 2
... Assay Kits are ideal for studying or ... GR Competitor Assay Kits contain partially purified ... of the following proprietary fluorescent glucocorticoid Fluormone ... (red assay kit), or GS Far Red ...
... complete kit contains enough separation ... a total of 5 x ... includes the StemSep red magnet ... and buffers for the specific ...
... * Source rat ... T25 plated cells $550.00, * ... 120 population doublings, * This ... complete ,growth medium M55007-08 and ...
... Tissue Arrays are intended for laboratory research ... fixed in neutral buffered formalin and embedded ... was performed by certified pathologists. Tissue ... and relocated into a new recipient paraffin ...
Biology Products: